HeyJaredCarlotta Eden
- Indexed articles, last 90 days
- 11
- Latest publication
- Sep 30, 2026
- Outlet visibility, for The Pharmaceutical Journal
- Top 1M sites
- Earliest in this view
- Sep 2, 2026
Latest articles
Regulator fails timely fitness-to-practise standard for eighth year running (opens the original)
Read excerpt
The General Pharmaceutical Council (GPhC) has failed to meet the Professional Standards Authority’s (PSA) standard on the timely resolution of fitness-to-practise (FtP) cases for the eighth consecutive year. In its annual performance review, published on 30 September 2026, the PSA — which sets standards for all UK health regulators — noted that the GPhC met 17 of its 18 ‘Standards of good regulation’. However, the annual performance review, which covered the time period from July 2025 to June 20
PDA gains full say on NHS pay and conditions negotiations after joining Staff Side Council (opens the original)
Read excerpt
The Pharmacists’ Defence Association (PDA) will now be able to fully contribute to negotiations on the pay and conditions of NHS staff on Agenda for Change contracts, after becoming a full voting member of the NHS Staff Side Council following two years as an ‘observer’. In a statement, published on 22 September 2026, the PDA said that because it is focused solely on pharmacists, issues “specific to the profession can be raised directly”. The PDA, which represents more than 40,000 pharmacists, ca
Scotland’s first drug-checking service to open as drug deaths rise by more than 10% (opens the original)
Read excerpt
Scotland’s first local drug-checking service will open in Glasgow in October 2026, allowing people to submit drugs for rapid analysis and receive harm-reduction advice alongside the results. The announcement came as the most recent figures from National Records of Scotland (NRS) show that drug use deaths in Scotland rose by 11% in 2025 to 1,133 — which is 116 more deaths than in 2024 and the sixth highest year on record. The rate of 21.4 deaths per 100,000 people is four times the rate in 2000,
Nasal adrenaline spray recommended for use in NHS Wales (opens the original)
Read excerpt
The All Wales Medicines Strategy Group (AWMSG) has recommended EURneffy, a 2mg nasal adrenaline spray, for the emergency treatment of anaphylaxis in NHS Wales. The recommendation applies to adults and children weighing 30kg or more, covering anaphylaxis caused by insect stings or bites, foods, medicines or other allergens, as well as idiopathic and exercise-induced anaphylaxis. And since the licence for EURneffy was extended to include the 1mg nasal spray for children aged 4 years and over weigh
Insulin storage in neonatal units should be digitally restricted, inquiry says (opens the original)
Read excerpt
Access to insulin in NHS neonatal units should be restricted using digital devices, with CCTV installed on storage units in the meantime, the Thirlwall Inquiry has recommended. The inquiry, commissioned in September 2023, examined events surrounding the deaths of several babies at the Countess of Chester Hospital between 2015 and 2018. Its final report, published on 15 September 2026, makes 17 recommendations, including that digital devices should be used to restrict access to insulin to authori
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For The Pharmaceutical Journal, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.